![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
B via Inhibition of the Prosurvival Akt Signaling PathwayDepartment of Surgery (D.D., X.G., S.A-H., A.L.D., S.A.D., S.C.G.) and Department of Neurology (H.J.), Henry Ford Health System, Detroit, Michigan
Our previous studies have shown that dietary pigment curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-16-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L)-induced apoptosis by inhibiting nuclear factor (NF)-
B. In the present study, we demonstrate that activated (phosphorylated) Akt kinase plays a pivotal role in regulation of NF-
B and sensitization of LNCaP and PC3 prostate cancer cells to TRAIL by curcumin. Curcumin inhibited the expression of phospho-Akt (p-Akt), which was not due to activation of phosphatase and tensin homolog deleted on chromosome 10 phosphatase activity by curcumin. Because NF-
B is a downstream target of Akt, we investigated whether inhibition of NF-
B by curcumin is mediated through suppression of p-Akt. Data demonstrate that treatment of PC3 cells with SH-6 (JAm Chem Soc 125:11441145, 2003), a specific inhibitor of Akt, or transfection with small inhibitory RNA (siRNA)-Akt not only inhibited p-Akt but also abrogated the expression and transcriptional activity of NF-
B. Furthermore, overexpression of constitutively active Akt1 in cancer cells prevented the inhibition of NF-
B by curcumin. In addition, treatment with SH-6 or transfection with siRNA-Akt sensitized PC3 cells to TRAIL-induced cytotoxicity. On the other hand, SH-6 does not inhibit NF-
B or sensitize DU145 cancer cells to TRAIL because these cells do not express p-Akt. Because expression of antiapoptotic Bcl-2, Bcl-xL, and X-chromosome-linked inhibitor of apoptosis protein (XIAP) is regulated by NF-
B, both curcumin and SH-6 decreased the levels of these proteins in PC3 cells through inhibition of NF-
B. Furthermore, gene silencing of Bcl-2 with siRNA-Bcl-2 sensitized PC3 cells to TRAIL. Collectively, these data define a pathway whereby curcumin sensitizes prostate cancer cells to TRAIL by inhibiting Akt-regulated NF-
B and NF-
B-dependent antiapoptotic Bcl-2, Bcl-xL, and XIAP.
Address correspondence to: Dr. Subhash C. Gautam, Surgical Research 4D, One Ford Place, Detroit, MI 48202. E-mail: sgautam1{at}hfhs.org
This article has been cited by other articles:
![]() |
Y. Jiao, J. Wilkinson IV, X. Di, W. Wang, H. Hatcher, N. D. Kock, R. D'Agostino Jr, M. A. Knovich, F. M. Torti, and S. V. Torti Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator Blood, January 8, 2009; 113(2): 462 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yu, G. Shen, T. O. Khor, J.-H. Kim, and A.-N. T. Kong Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism Mol. Cancer Ther., September 1, 2008; 7(9): 2609 - 2620. [Abstract] [Full Text] [PDF] |
||||